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The developing immune system and central nervous system in the fetus and child
are extremely sensitive to both exogenous and endogenous signals. Early immune
system programming, leading to changes that can persist over the life course, has
been suggested, and other evidence suggests that immune dysregulation in the early
developing brain may play a role in neurodevelopmental disorders such as autism
spectrum disorder and schizophrenia. The timing of immune dysregulation with respect to
gestational age and neurologic development of the fetus may shape the elicited response.
This creates a possible sensitive window of programming or vulnerability. This review will
explore the effects of maternal prenatal and infant nutritional status (from conception until
early childhood) as well as maternal prenatal stress and anxiety on early programming of
immune function, and how this might influence neurodevelopment. We will describe fetal
immune system development and maternal-fetal immune interactions to provide a better
context for understanding the influence of nutrition and stress on the immune system.
Finally, we will discuss the implications for prevention of neurodevelopmental disorders,
with a focus on nutrition. Although certain micronutrient supplements have shown
to both reduce the risk of neurodevelopmental disorders and enhance fetal immune
development, we do not know whether their impact on immune development contributes
to the preventive effect on neurodevelopmental disorders. Future studies are needed to
elucidate this relationship, which may contribute to a better understanding of preventative
mechanisms. Integrating studies of neurodevelopmental disorders and prenatal exposures
with the simultaneous evaluation of neural and immune systems will shed light on
mechanisms that underlie individual vulnerability or resilience to neurodevelopmental
disorders and ultimately contribute to the development of primary preventions and early
interventions.
Keywords: programming, immunology, mental health, neurodevelopmental disorders, psychiatric disorders,
nutrition, anxiety, stress
INTRODUCTION
The prenatal period is a sensitive time during which intrauterine
exposures can modulate the course of development and confer
an enduring effect on the offspring. Epidemiological and animal
studies have demonstrated that prenatal programming of physio-
logical systems can alter the growth and function of organ systems
and pathology into adulthood (Szekeres-Bartho, 2002; Mold and
McCune, 2012). For example, early immune system program-
ming would give rise to changes in the fetal immune system that
persists over the life course. In addition, some evidence based on
animal, epidemiological and genetic studies suggests that immune
dysregulation in the developing brain may play a role in neu-
rodevelopmental disorders such as autism spectrum disorder and
schizophrenia (Brown et al., 2000a, 2004; Susser et al., 2000;
Meyer et al., 2009; Patterson, 2009, 2012; Meyer and Feldon, 2010;
Bilbo and Schwarz, 2012; Aberg et al., 2013).
During pregnancy, the maternal and fetal immune systems
communicate in a bi-directional manner. The maternal immune
system develops an active immunologic tolerance against fetal-
placenta antigens (recognition and activation). Following recog-
nition, the maternal immune system reacts with a wide range
of protective immunoregulatory mechanisms, which are critical
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for the maintenance of a normal pregnancy, the development of
the fetal immune system, and maintaining maternal immuno-
competence (Szekeres-Bartho, 2002; Mold and McCune, 2012;
Erlebacher, 2013).
While well-controlled maternal immune responses play a pos-
itive physiological role in fetal immune and nervous system
development, an inappropriatematernal immune activation (e.g.,
increased levels of pro-inflammatory cytokines) may contribute
to an increased risk in the offspring of neurodevelopmental dis-
orders, autoimmune diseases and allergies later in life (Brown
et al., 2004; Bresnahan et al., 2005; Ellman and Susser, 2009;
Bilbo and Schwarz, 2012). The timing of immune dysregulation,
with respect to gestational age and neurologic development of
the fetus, may be significant, as distinct immune and neurode-
velopmental programs are affected differently depending on fetal
stage. This creates a sensitive window of vulnerability (Dietert and
Dietert, 2008).
The fetal immune system is particularly vulnerable to disrup-
tions caused by environmental factors that have an impact on
the maternal immune system, such as malnutrition, toxins and
stress. We will discuss the effects of maternal and infant nutri-
tion and maternal stress and anxiety on perinatal programming
of immune function, and how this might influence neurodevel-
opment (Palmer, 2011; PrabhuDas et al., 2011; O’Connor et al.,
2013b).
Based on these findings, we will discuss the implications for
preventions of neurodevelopmental disorders focused on nutri-
tion, as diet is among the more easily manipulated, safe, and
promising avenues for intervention. We will highlight exam-
ples of three micronutrients—folate, iodine, and vitamin D—and
discuss their proven and potential preventive effects on neurode-
velopmental disorders. Although certain micronutrient supple-
ments have shown to both reduce the risk of neurodevelopmental
disorders and enhance fetal immune development, we do not
know whether the impact on immune development contributes
to the preventive effect on neurodevelopmental disorders. Future
studies are needed to elucidate this relationship, which could con-
tribute to better understanding of the mechanisms of prevention
and in turn perhaps improvements in these interventions.
MATERNAL-FETAL IMMUNE SYSTEM INTERACTIONS
Maternal-fetal immune system interactions are characterized
by bi-directional communications that rely upon the maternal
immune system’s recognition of antigens (derived from fetal,
placental and paternal genomes) at the maternal-fetal interface,
as well as a bi-directional transplacental trafficking of fetal and
maternal cells throughout pregnancy (Taglauer et al., 2010; Mold
and McCune, 2012; Nelson, 2012).
As the fetus is not in direct contact with maternal tissue,
the placenta is the predominant source of antigens for T-cell
priming and the direct target of any evoked maternal immune
response. The maternal immune tolerance against fetal-placenta
antigens depends on cell-cell interactions that take place between
maternal immune cells resident in the decidua (natural killer
cells and macrophages) and trophoblast antigens, as well as on
immunoregulatory mechanisms (e.g., cytokines) that are critical
for maintenance of a normal pregnancy, development of the fetal
immune system, and maternal immunocompetence (Szekeres-
Bartho, 2002; Mold and McCune, 2012; Erlebacher, 2013).
There are two main surfaces between the maternal and pla-
cental cells: (1) the placenta, located within the maternal decidua
(a tissue layer derived from the endometrium) where placental
trophoblasts and uterine leukocytes interact (Hanna et al., 2006;
Erlebacher, 2013), and (2) the placental villi, where circulating
maternal blood comes into contact with placental antigens, which
can be shed directly into maternal circulation to modulate the
maternal immune response (Hanna et al., 2006; Sargent et al.,
2006; Erlebacher, 2013).
Fetal microchimerism (FMc) (i.e., the presence of fetal cells
or DNA within maternal circulation and tissue) and maternal
microchimerism (Mc) (i.e., the presence of maternal cells or
DNA in the fetus) have been shown to persist long after birth
(Bianchi et al., 1996; Maloney et al., 1999; Gammill and Nelson,
2010). FMc has been hypothesized to have both positive and
negative effects on maternal cancer, endocrine and autoimmune
diseases, but its role is still debated and controversial (Nelson,
1998; Feitsma et al., 2007; Fugazzola et al., 2011). FMc has
been associated with several autoimmune disorders such as sys-
temic sclerosis, juvenile dermatomyositis and juvenile diabetes;
however, its role in these disorders still remains unclear (for
review see Nelson et al., 2007; Gammill et al., 2010; Leveque and
Khosrotehrani, 2011; Nelson, 2012).
DEVELOPMENT OF MATERNAL IMMUNE TOLERANCE
Decidua natural killer cells, macrophages and trophoblast antigens
During the first trimester, the maternal decidua is mostly com-
prised of a unique type of natural killer cells called decidua
natural killer cells (dNK), which are not present outside the con-
text of pregnancy. The remaining maternal decidua is comprised
of macrophages (CD 209+), while T-cells, dendritic cells and
specialized B cells are scarce (Chazara et al., 2011; Erlebacher,
2013).
The primary role of dNK cells is to promote uterine vascular
changes in the decidua in order to maximize maternal blood flow
through the placenta. This process occurs by transforming the
spiral arterioles into high-capacitance, low-resistance vessels, and
by promoting trophoblast migration to replace the endothelium
of these vessels with trophoblasts. The dNK-trophoblast interac-
tions generate distant signals that trigger perivascular dNK cell
and macrophage accumulation deeper within the decidua, fur-
ther facilitating the vascular remodeling process of the arteriole
(Hanna et al., 2006; Chazara et al., 2011; Erlebacher, 2013).
dNK cells can interact with trophoblast cells through two sets
of receptors: (a) the killer-activating receptor, which recognizes a
number of different molecules present on the surface of nucle-
ated cells, and (b) the killer-inhibitory receptors (KIR family),
which recognize the major histocompatibility complex (MHC)
class I molecules that are typically present on all nucleated cells.
When a killer-activating receptor is activated, a “kill” instruction
is issued; however, this signal is normally overridden by the signal
sent by the killer-inhibitory receptors that recognize MHC class
I molecules. As all nucleated cells normally express MHC class I
molecules on their surface, dNK cells will not destroy them. A
lack of MHC class I molecules (due to infection or malignant
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transformation) leads to no inhibitory signal from the KIR and
the consequent activation of dNK cells (Moretta et al., 1997;
Delves and Roitt, 2000).
The dNK cell expresses a reduced cytotoxicity, which may
play a role in protecting trophoblast cells from maternal anti-
fetal responses. Some potential mechanisms have been suggested
concerning the inhibition of dNK function, including (a) dNK
interaction with anti-inflammatory cytokine IL-10, (b) dNK
interaction with class Ib molecules (HLA-E or -G), and (c) a spe-
cific dNK-KIR coupled interaction with class Ia HLA-C2 alleles
in the trophoblast, which leads to a strong activation of KIR and
therefore inhibitory signal to dNK cells (for review see Mold and
McCune, 2012; Erlebacher, 2013).
Macrophages in the decidua play an important role in tis-
sue remodeling, maintenance of pregnancy, and parturition, but
have also been associated with the development of preeclamp-
sia and intrauterine growth restriction. Though much of the
decidual macrophage biology remains unknown, these cells are
skewed toward an M2-like macrophage phenotype, produce ele-
vated levels of IL-10 and generate other factors that promote
apoptosis, tissue remodeling, scavenging, debris clearance, and
the generation of immunosuppressive tissue microenvironments
(Heikkinen et al., 2003; Renaud and Graham, 2008; Erlebacher,
2013).
Maternal immunoregulatory mechanisms
The bi-directional relationship of the fetal-maternal immune
response is also mediated by the production of cytokines
(Breckler et al., 2008; Prescott et al., 2010). Maternal immune
recognition of fetal antigens results in cytokine production that
promotes blastocyst implantation and placenta growth, while
embryogenic antigen expression on the placenta will modify
maternal cytokine production (Breckler et al., 2008; Prescott et al.,
2010).
An imbalance in maternal cytokine production can lead to
fetal resorption (Wegmann et al., 1993; Tangri et al., 1994). In
mice models, high doses of pro-inflammatory cytokines such as
interferon (INF)-γ and tumor necrosis factor (TNF)-α [a T helper
(Th)1 cytokine] have been associated with spontaneous abor-
tion (Chaouat et al., 1990; Szekeres-Bartho, 2002). Conversely,
healthy pregnancies and maternal immune tolerance are associ-
ated with a preponderance of Th2 cytokines (e.g., IL-10, IL-13),
humoral immunity and reduced cell-mediated immunity (Th1-
type cytokines) in response to both environmental antigens and
fetal alloantigens (Raghupathy et al., 1999; Breckler et al., 2008,
2010).
Another important maternal immunoregulatory mechanism
associated with pregnancy outcome is the balance between
Th17 cells and the regulatory T-cells known as Tregs (originally
termed suppressor T-cells). Tregs can suppress both Th1and Th2
responses (O’Garra and Vieira, 2004), while Th17 cells are impor-
tant for the induction of autoimmunity and protection against
infectious diseases. The regulation of the Tregs/T17 cell balance is
critical in immunity and immunopathology and has been demon-
strated to play an important role in maternal immune tolerance
to fetal antigens and in fetal and neonatal immune develop-
ment (Gustafsson et al., 2008; Prescott and Clifton, 2009). There
is also evidence that the Treg (CD4+CD25+FoxP3+) regulatory
response is initiated even prior to conception, following exposure
to paternal antigens in seminal fluid (Robertson et al., 2009).
DEVELOPMENT OF THE FETAL IMMUNE SYSTEM AND TOLERANCE
Studies have shown that the fetal immune system actively
responds to exogenous antigens such as infectious agents and vac-
cines (Marchant et al., 2003; Rastogi et al., 2007). However, in the
absence of an additional signal, the fetal immune response tends
toward an active tolerance rather than immunity (Munoz-Suano
et al., 2011). This response pattern has important implications
for understanding the impact of prenatal or early life exposure to
infections or vaccines.
Development of the immune system: sensitive window of immune
vulnerability
The development and maturation of the immune system starts
early in fetal life and continues through infancy and early
childhood. There is a period in which the immune cells have
an increased vulnerability and susceptibility to environmental
insults, such as malnutrition, stress and environmental contam-
inants. An early vulnerable window occurs when the tissues are
being seeded by precursors of immune cells and varies depending
on the type of immune cell (e.g., 4–7 weeks for myeloid-derived
cells and 8–18 weeks for lymphoid cells) (Dietert and Dietert,
2008). However, there is no absolute consensus on the time-
frame of the window of vulnerability, as both myeloid-derived
cells and lymphoid cells continue to expand as gestation proceeds
(Leibnitz, 2005). In addition, post-natal exposure (i.e., perina-
tal period and early childhood) to environmental insults has also
been shown to modulate immune response (Suglia et al., 2010),
but this topic is outside the scope of this review.
Myeloid-derived cells, such as macrophages, dendritic cells,
skin Langerhans cells, and brainmicroglia cells, begin to populate
the tissues during gestational week 4–7 and continue to increase
in number throughout the second trimester (Leibnitz, 2005).
The thymus is populated by lymphoid cells through the process
of lymphocyte maturation and positive and negative selection
(central tolerance) in gestational week 8–18, with continuing
expansion of population within the thymus as gestation proceeds
(Leibnitz, 2005). The first mature T-cells are seen in peripheral
tissues in gestational week 10–12 and are circulating in significant
number by the end of the second trimester (for review see Mold
and McCune, 2012).
Development of immune tolerance
Although the mechanism underlying the development of toler-
ance in human beings remains unknown, some evidence suggests
that it can be generated in response to maternal alloantigens that
cross the placenta (for a detailed review see Mold and McCune,
2012).
During thymic maturation, potential self-reactive T-cells are
deleted by a positive and negative central tolerance process.
Positive tolerance refers to the process by which T-cells are
exposed and bind (via T-cell receptors) to “self” MHCmolecules.
If T-cells fail to bind or bind with too high affinity to self-
MHC molecules, then they are deleted (Griesemer et al., 2010).
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Following positive selection, thymocytes undergo negative selec-
tion, in which specialized epithelial cells and thymic antigen-
presenting cells expose a broad range of self-peptides to T-cells.
If T-cells respond to any of these antigens, they are deleted
(Blackman et al., 1986). As a result, T-cells that bind to self-MHC
molecules in conjunction with a foreign peptide, but do not rec-
ognize self-antigens, are selected. Disruption of the thymic mat-
uration and clonal selection will influence not only the neonatal
T-lymphocyte response, but also the likelihood of retaining auto-
reactive T-lymphocytes later in life (Dietert and Piepenbrink,
2006).
Conversely, peripheral tolerance has been shown to play an
important role in preventing autoimmunity and maintaining tol-
erance. It involves several types of regulatory T-cells (Tregs),
although the best-characterized one is CD4+, which has high
affinity receptors for IL-2 (CD25+) and the transcriptor fac-
tor Foxp3 (Hori et al., 2003). In humans, between the first and
second trimester of gestation, there is an increased number of
Tregs (CD4+CD25+), suggesting an active tolerogenic process
(Cupedo et al., 2005). Tregs are generated either at the thymus
by the process of T-cell selection, or at the peripheral tissue when
naïve T-cells are activated in the presence of specific immuno-
suppressive factors (e.g., transforming growth factor (TGF)-ß)
(Chen et al., 2003). It has been hypothesized that during develop-
ment, expressions of high levels of TGF-ß in the fetal peripheral
lymphonodus bias the fetal T-cell response toward a tolerogenic
response, generating a large pool of fetal Tregs that are capa-
ble of recognizing and suppressing peripheral antigens, including
maternal alloantigens (Mold and McCune, 2012).
Distinct features of fetal adaptive immune system associated with
tolerance
Some evidence suggests that several distinct features of the fetal
adaptive immune system play a role in the development of
fetal tolerance against antigens that are present in utero (Mold
and McCune, 2012). One process involves the presence of a
specific fetal T-cell subpopulation called Vγ3δ5 T-cells, which
are suggested to play a role in maintaining tissue homeosta-
sis by regulating apoptosis and epidermal cell growth rather
than by generating immunity to foreign antigens like adult
α/ß T- cells (Sharp et al., 2005). Another mechanism includes
the presence of a specific B-cell (IgM) subpopulation that is
hypothesized to produce mature IgM cells that are broadly
reactive, thus providing protection immediately following birth
(Bhat et al., 1992).
Another unique feature of the fetal immune system is that
fetal and neonatal T-cells and B-cells express auto-reactive anti-
gen receptors that can also cross-react with peptides derived from
unrelated antigens, providing a greater potential to respond to a
broader range of infectious antigens, thus overcoming the limita-
tions of having a smaller T-cell pool at birth (Gavin and Bevan,
1995; Mold and McCune, 2012).
Finally, fetal and adult hematopoietic stem cells (HSC) have a
distinct phenotype and function, and are likely to generate differ-
ent populations of mature hematopoietic cells (Ikuta et al., 1990)
(for reviewMold andMcCune, 2012).While fetal HSCs are highly
proliferative, undergo extensive self-renewal and are primarily
maintained in the fetal liver, adult HSCs are relatively quiescent
andmainly reside in the bonemarrow.However, it is still not clear
what mechanisms are involved in the transition from fetal HSC to
adult HSC, or if fetal and adult HSC populations coexist during
the fetal or neonatal period; studies have shown a dramatic shift in
the turnover rates of hematopoietic cells between the first and sec-
ond year of life (Rufer et al., 1999). These findings have important
implications for understanding tolerance and immunity to infec-
tious diseases, susceptibility to the development of atopic disease,
and responses to vaccines during pregnancy and during the
neonatal period.
The fetal immune system and central nervous system (CNS)
It is now well-established that the neurological and immune sys-
tems communicate with each other in a bi-directional manner.
The CNS can regulate the immune system via both neuronal and
hormonal pathways. Conversely, the immune system can affect
the CNS either by local or peripheral processes (Marques-Deak
et al., 2005; Silverman et al., 2005; Silverman and Sternberg, 2008;
Dantzer, 2009; Marques et al., 2009; Thayer, 2009; Dantzer et al.,
2011; Raison and Miller, 2011).
Although definitive pathways by which immune dysfunc-
tion can contribute to neurodevelopmental disorders are still
not completely understood, the presence of maternal pathogenic
autoantibodies, immune activation and increased levels of pro-
inflammatory cytokines in the fetal brain can exert a negative
impact on brain development if the time of exposure overlaps
with major processes in neurodevelopment, such as cell migra-
tion, axonal elongation and dendritic tree maturation (Bilbo and
Schwarz, 2009; Meyer et al., 2009; Patterson, 2011, 2012; Depino,
2013).
Because the blood-brain barrier (BBB) is not fully developed
during the fetal period, larger molecules, such as antibodies,
may have greater access to the brain (Diamond et al., 2009).
BBB permeability increases as a result of microglia cell activa-
tion, infection, trauma or stress, and thereby enhances the risk
of exposing the brain to insults and environmental stimuli that
may impact neurodevelopment (Prat et al., 2001).
Maternal antibodies, transferred to the fetus by the placenta
(starting as early as 6 weeks of gestation with a rapid increase
by week 26–34) or to the infant through breast-feeding, play
an important role in providing passive immunity to the fetus
or neonate. However, the presence of pathogenic autoantibod-
ies targeting the CNS in the developing fetus and neonate can
be deleterious. It has been proposed that brain-specific maternal
autoantibodies might underlie multiple congenital and neurode-
velopmental disorders (for review see Billington, 1992; Lee et al.,
2009; Fox et al., 2012).
Peripheral activation of the immune system with produc-
tion of cytokines can affect the CNS indirectly (by activation of
the hypothalamic-pituitary-adrenal (HPA) axis) or directly (via
cytokines crossing the BBB (Silverman et al., 2005). In the CNS,
microglia, astrocytes and other CNS cells produce and express
receptors for cytokines in response to disturbances in homeostasis
(Bilbo and Schwarz, 2009, 2012).
An imbalance between pro- and anti-inflammatory cytokines,
favoring a pro-inflammatory response, has been associated
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with abnormal brain development and increased risk of neu-
rodevelopmental disorders, including schizophrenia and autism
(Brown et al., 2000a,b; Meyer et al., 2006, 2009; Deverman and
Patterson, 2009; Boksa, 2010; Capuron and Miller, 2011; Bilbo
and Schwarz, 2012; Depino, 2013). During normal brain devel-
opment cytokines are expressed at very low levels, interact with
all neural and non-neural cell types (e.g., microglia and endothe-
lial cells) and play a role in brain development (for review see
Deverman and Patterson, 2009). However, increased cytokine lev-
els due to maternal immune activation (MIA) can potentially
induce brain damage (Dammann and O’Shea, 2008; Deverman
and Patterson, 2009; Patterson, 2009). Interestingly, an imbalance
in cytokine expression (pro- vs. anti-inflammatory cytokines)
may be even more relevant, as a shift toward an excess of anti-
inflammatory cytokines has also been associated with abnormal
brain and behavioral development (Dhabhar et al., 2009; Meyer
et al., 2009).
MIA can be due to viral, bacterial or parasitic infections.
Animal studies on MIA using mice and rats have demonstrated
that early life exposure to infections or immune activation can
lead to cognitive, behavioral or brain morphological abnor-
malities that are relevant to autism, schizophrenia and other
psychosis-related disorders (Meyer and Feldon, 2010; Brown and
Patterson, 2011; Hsiao and Patterson, 2011; Meyer et al., 2011;
Patterson, 2011, 2012). Notably, long-lasting brain and behav-
ioral abnormalities following MIA have also been demonstrated
(Meyer and Feldon, 2010; Meyer et al., 2011; Garay et al., 2013).
MIA has also been described in human populations.
Epidemiological studies have indicated that prenatal exposure to
a wide variety of infections (e.g., influenza, rubella, toxoplasma
gondii, etc.) is associated with an increased risk for schizophre-
nia and autism. For review see Susser et al. (2000); Brown et al.
(2004); Bresnahan et al. (2005); Atladottir et al. (2010); Brown
and Patterson (2011); Moore and Susser (2011).
WHAT WOULD A PRENATAL PROGRAMMING INFLUENCE ON
OFFSPRING IMMUNE FUNCTION LOOK LIKE?
The complexity of the immune system means that, inevitably, no
single study would be equipped to examine each of the multiple
aspects of the functioning immune system, let alone the dynamic,
systemic nature of its actions. For example, among those stud-
ies assessing variation in cytokines, the vast majority focuses on
fewer than a handful of the multitude of cytokines identified.
This could easily lead to misspecification of effects, given that
cytokines are pleiotropic, can act in an antagonistic, synergistic
or redundant manner with other cytokines, and have numer-
ous possible functions in the body. The lesson is that it is no
easy task to identify which aspects of the immune system might
be affected by maternal prenatal nutrition factors and/or stress.
Guidance for developing protocols for researching prenatal stress
and anxiety in humans is available from animal studies and from
the accelerating research activity on inflammation as an outcome
of psychological risks and characteristics—although much of the
work is still in the developmental and exploratory phases. What
is clear is that general statements about prenatal malnutrition and
stress/anxiety influencing the “immune system” are too broad and
vague to be illuminating. Going forward, it will be important to
clarify which specific aspects of immune function are predicted
by prenatal risk factors, and the methods by which an association
is demonstrated.
The notion that maternal prenatal malnutrition and
stress/anxiety may alter some or many aspects of the developing
immune system of the fetus/child is intriguing for several reasons.
Perhaps the most obvious is that pregnancy is in itself a major
immunological challenge for the mother and fetus. Indeed,
alteration of the pregnant mother’s immune system by the
developing embryo is essential if the fetus is to be carried to term.
Many of these changes have been well documented and were
discussed in sections Decidua Natural Killer Cells, Macrophages
and Trophoblast Antigens and Maternal Immunoregulatory
Mechanisms. Some of these changes are captured by the alter-
ation in autoimmune diseases in the course of pregnancy (Wilder,
1998). Any focus on in utero predictors would necessarily require
some attention to the normative immune challenges created by
the pregnancy.
If there were a prenatal programming mechanism for immune
function in the child, then it is worth considering what such an
effect would look like. One specific question is which components
of the immune system might be programmable. As indicated
above, the immune system is a complex array of moving and
interconnected parts, and this confounds decisions about which
markers to assess and what meaning the results might hold. As
will be seen from the review of studies below, there are some
trends in the operationalization and execution of immune sys-
tem measurement. However, it is far from clear which aspects
of the immune system might be especially susceptible to pro-
gramming influence, or why that might be. A second, broader
consideration is that it would not make much evolutionary sense
for a species if its immune system—an essential feature for sur-
vival and reproductive fitness—could be “damaged” by a risk
as potentially common as prenatal stress and anxiety. Therefore,
rather than view immune outcomes in terms of simple “deficits,”
it may be more accurate to view alterations in the immune system
related to prenatal malnutrition and stress/anxiety as adaptations
to early in utero exposures. The fundamental notion here is that
the development of immunity in the fetus and infant is mal-
leable and sensitive to input; the immune system “learns from”
or responds to exposures. This model comports well with the
adaptive response and carrying-forward of effects that is built
into the immune programming hypothesis. In this context, it is
interesting that at least some studies reporting a link between pre-
natal stress/anxiety and immune outcomes report alteration in
the type of immune response (e.g., an exaggerated bias toward
a type 2 response; see below) rather than merely reduced immune
competence. Similarly, the link between prenatal stress/anxiety
and asthma implies not a simple deficit in the immune system
but an alteration in the development of the immune system that
increases the likelihood of autoimmune diseases.
THE IMPACT OF MATERNAL AND INFANT NUTRITIONAL
STATUS ON IMMUNE SYSTEM DEVELOPMENT AND
NEURODEVELOPMENT
Maternal and infant nutrition may modulate the immunologic
development of the fetus and young infant and permanently alter
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immunologic and regulatory mechanisms, which may affect the
risk for later disease (Palmer, 2011). Adequate nutrition is neces-
sary both for establishing the immune system, through normal
organogenesis and development, and for an adequate immune
response, through the normal proliferation of immune cells and
the synthesis of secretory products and acute-phase proteins.
Some nutrients, like antioxidants, are also needed to control or
inhibit the immune response. Finally, the immune response in
itself may affect nutritional status by decreasing levels of cer-
tain nutrients, exemplified by the decrease in iron, pyridoxine
and tryptophan associated with inflammation (Lotto et al., 2011;
Gaffney-Stomberg and McClung, 2012; von Bubnoff and Bieber,
2012).
MATERNAL MALNUTRITION
During pregnancy, maternal malnutrition hampers placentation,
with resulting changes in placental size, morphology and blood
flow (Belkacemi et al., 2010) that thereby reduce the supply of
nutrients to the fetus. The subsequently compromised fetal nutri-
tion status has profound effects on organogenesis, growth and
fetal programming and has been associated with both short- and
long-term effects on development and morbidity (Jansson and
Powell, 2007).
Maternal malnutrition interferes with both the quality and
quantity of immune factors transferred prenatally through the
placenta and postnatally through the mammary gland (Palmer,
2011). Maternal IgG is actively transported through the placenta,
appearing in the fetus (Simister, 2003) and remaining intact in
the infant up to the age of 3–6 months (Palmer, 2011). The high-
est levels of maternal IgG in the cord blood is found during the
last 4–6 weeks of pregnancy, so premature birth is associated with
lower IgG levels in the infant (Malek et al., 1996). Reduced IgG
levels have also been observed in small-for-gestational-age infants
and in infants born to mothers with a lower than normal weight
for height (Okoko, Wesumperuma, and Hart, 2001). In human
milk the main antibody is IgA, which constitutes part of the
mucosal immune system that controls epithelial colonization of
microorganisms and inhibits penetration of harmful substances
(Brandtzaeg, 2011).
AWINDOW OF OPPORTUNITY
Development of oral tolerance depends on interactions between
maternal, infant and environmental factors, including genet-
ics, food and bacterial colonization. Breast milk is essential
for development of oral tolerance and contains immunoglobu-
lins, cytokines, growth factors, lysozyme, lactoferrin, and human
milk oligosaccharides. Maternal and infant nutrition modulate
immune system development by providing food antigens. Food-
derived antigens are transferred through the placenta into the
amniotic fluid and cause prenatal formation of antigen-specific
IgE antibodies (Kondo et al., 1992). After birth, introduction of
breast milk, formula and solid food influences immune matura-
tion and response in a complex interaction with gut flora (Calder
et al., 2006). There appears to be a window of opportunity for
optimal development of oral tolerance between 4 and 6 months
of age. Impaired oral tolerance is associated with gut inflamma-
tory disease, food allergies and celiac disease (Verhasselt, 2010).
Impaired oral tolerance was exemplified by an experience in
Sweden between 1984 and 1996, during which an epidemic of
coeliac disease in children <2 years occurred following chang-
ing of feeding habits and delaying introduction of gluten from
4 months to 6 months (Ivarsson et al., 2013).
MICRONUTRIENTS
Maternal deficiency of certain micronutrients is reported to per-
manently affect the immune system, but much remains unknown
about this area. Gestational zinc deficiency has been associated
with reduced thymic and spleen size, decreased antibody con-
centrations and impaired lymphocyte activity (Wellinghausen,
2001). Nutritional factors related to single carbon metabolisms,
choline, folate (which is necessary for DNA methylation) and
vitamins B2, B6, and B12 are important modulators for epige-
netic mechanisms (Dominguez-Salas et al., 2012). Changes in
the epigenetic regulation of immune system development have
been linked to various pathological conditions, among them
allergic risk and asthma development (Martino and Prescott,
2011). Dietary folate is postulated to be necessary for the
maintenance of Forkhead box P3 (FOXP3) Tregs in the colon,
a subset of inhibitory CD4+ helper T-cells that restrain the
immune response to infection, inflammation and autoimmunity.
Conversely, mice fed a diet deficient in folic acid have a higher
susceptibility to intestinal inflammation (Kinoshita et al., 2012).
Fat-soluble vitamins A and D play important roles in both
cell-mediated and humoral immune responses (Wintergerst et al.,
2007). Vitamin D is a direct regulator of antimicrobial innate
immune responses, can inhibit lymphocyte proliferation (Wang
et al., 2004) and promote development of Tregs (Lemire et al.,
1984). Vitamin D deficiency in healthy neonates has been linked
to an increased risk of respiratory syncytial virus infection during
the first year of life. Vitamin A has also been shown to be neces-
sary for the development of de novo Tregs in the gut (Sun et al.,
2007). Vitamin A deficiency has been reported to seriously affect
hematopoiesis (Oren et al., 2003) and has been associated with a
substantial increase in morbidity and mortality, especially due to
diarrhea and measles in young infants (Fawzi et al., 1993).
It has also been suggested that maternal intake of vitamin E
and polyunsaturated fatty acids during pregnancy may influ-
ence development of the immune system and be implicated
in childhood asthma and allergy. Published reports, however,
show conflicting results, and intervention studies are still lacking
(Devereux, 2010).
ENVIRONMENTAL CONTAMINANTS
Food not only provides nutrients but is also the most impor-
tant source of environmental contaminants, specifically persistent
organic pollutants (POPs). This is a group of highly resistant
chemicals, including dioxins, furans, polychlorinated biphenyls
and organochlorine pesticides, created by industrial activities and
found in food, with the highest concentrations in fatty fish (pri-
marily farmed salmon) (Schecter et al., 2010). These highly toxic
compounds have been found to cross the placenta and to be
excreted in breast milk (Fromme et al., 2010), thereby effec-
tively clearing the amount of POPs in maternal tissue by up to
94% (Thomsen et al., 2010; Whitworth et al., 2012). The rapidly
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developing infant receiving this breast milk has immature organ
systems and is especially vulnerable for toxic effects.
Early life exposure to various xenobiotics, including POPs, is
associated with developmental immunotoxicity, which has been
linked to neurodevelopmental disorders like autism spectrum dis-
orders (for review see Dietert and Dietert, 2008). Epidemiological
and human studies have demonstrated that there is a complex
interaction between the immune system, environmental pollu-
tants and neurodevelopment, although the exact mechanisms are
still not well understood (Park et al., 2010). However, pre-, peri-
and postnatal exposure to POPs is clearly associated with brain
damage (Ribas-Fito et al., 2001; Walkowiak et al., 2001).
GUT MICROBIOTA
Postnatally, infant nutrition, together with other factors like
gestational age, mode of delivery, bacterial environment and
use of antibiotics, also influences the composition of the gut
microbiota. The enteric nervous system, which provides a bi-
directional communication pathway between the brain, gastroin-
testinal cells and enteric microbes (termed the brain-gut-enteric
microbiota axis), is important for immunological and neurolog-
ical development, as well as later health. Interactions between
microbes and gut mucosa cells foster immunological tolerance
and recognition of pathogens, regulate the subsequent pro-
duction of various pro- and anti-inflammatory cytokines, and
stimulate Th17 cells and Toll-like receptors, which can differ-
entiate between commensal and pathogenic bacteria and trigger
immune processes.
The microbiota may also play a role in regulation of the HPA
system. Animal studies in mice have observed an association
between gut microbes and levels of brain-derived neurotrophic
factor in the cortex and hippocampus, and related this to changes
in brain plasticity (Sudo et al., 2004). Malnutrition has been also
associated with stress and activation of the HPA axis (Seckl and
Meaney, 2004). This is further outlined in the next section.
THE IMPACT OF MATERNAL PRENATAL STRESS AND
ANXIETY ON IMMUNE SYSTEM DEVELOPMENT AND
NEURODEVELOPMENT
Experimental animal studies in a very wide range of species
demonstrate reliable links between prenatal stress and a
wide range of outcome measures to a considerable degree.
This research agenda has been systematically translated to
human/clinical research programs in the past decade or so, with
notable reported parallels (Talge et al., 2007; O’Donnell et al.,
2009). Prenatal programming from maternal stress is now a sig-
nificant line of investigation, with many active research programs
assessing a wide range of outcomes and mechanisms.
One translation of the prenatal stress paradigm for human
development that has only recently attracted attention is the asso-
ciation between prenatal stress and immune outcomes. Studies
linking immune function with prenatal stress are notable for at
least two reasons. The first is the possibility that prenatal stress
or anxiety could influence the developmental programming for
vulnerability to infectious disease. Second, such a link would
further amplify the potential public health impact of maternal
prenatal stress or anxiety. That is because clinically significant
prenatal stress and anxiety is widely-reported to be common
(Heron et al., 2004) and, moreover, disturbances in behavior
and cognition linked to maternal prenatal stress and anxiety are
not limited to the clinical extremes (Huizink et al., 2003). These
observations compound the obvious public health relevance of
infectious diseases in children. It is clear that there is variation
in susceptibility to infectious disease; if this variation has pre-
natal origins, then there could be significant scope for prenatal
preventive interventions as treatment.
EMPIRICAL RESEARCH LINKING PRENATAL STRESS TO OFFSPRING
IMMUNE OUTCOMES
There is a growing empirical base supporting the hypothesis
that prenatal stress and anxiety is associated with several differ-
ent kinds of immune system alterations in the offspring/child;
the most persuasive evidence derives from experimental animal
studies.
EXPERIMENTAL ANIMAL WORK
The hypothesis that prenatal stress alters the immune response in
the animal has received wide-spread support in the rat, mouse,
and other animal models (Kay et al., 1998; Merlot et al., 2008;
Couret et al., 2009). For example, in a study of C57BL/6malemice
offspring of prenatally stressed dams, Diz-Chaves and colleagues
(2013) found a variety of prenatal stress effects on immune
responses, including increased expression of pro-inflammatory
cytokines IL-1b and TNF-alpha in the hippocampus and TNF-
alpha expression after Lipopolysaccharides (LPS) stimulation.
These findings are notable for highlighting some of the param-
eters that need to be configured in studies, such as the potentially
important distinction between observing the immune system
markers during a resting state and response to an immunologi-
cal challenge, and the location of the immune cell types that are
targeted.
Questions about the usefulness of rat and mouse models for
understanding inflammatory responses in humans have been
raised based on a minimal overlap in genetic profile of the inflam-
matory response between the mouse and human (Seok et al.,
2013). It is therefore important that there is also a sound body
of research on prenatal stress and offspring immune response in
a non-human primate model. In a series of studies, Coe and col-
leagues reported reliable links between prenatal stress and specific
immune outcomes in infant and juvenile primates. For exam-
ple, Coe (Coe et al., 1996) found that prenatal administration
of adrenocorticotropic hormone (ACTH) (a precursor to corti-
sol, that might well be elevated by stress) in a Rhesus monkey
model was associated with reduced T-suppressor cell activity
in the offspring. In another report in the same species, they
(Coe et al., 2002) linked prenatal stress to reduced levels of IL-
6 and TNF-alpha in a stimulation model (with LPS) that may
be accounted for by elevated HPA axis function in the stressed
animal. These data suggest that HPA axis activity may be a likely
cause of this diminished immune response, perhaps because of
a higher set point for HPA axis activity. This and other possible
mechanisms of effect are discussed below. The key observation at
this point is that experimental non-human primate work, which
has causal leverage not gained in human studies, shows reliable
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links between prenatal stress and several markers of immune
competence in the juvenile and adult offspring.
HUMAN RESEARCH LINKING PRENATAL STRESS/ANXIETY TO
IMMUNE OUTCOMES IN THE CHILD
A link between the experiences of, or exposure to, stress and
reduced immune competence in children dates back many years
(Meyer and Haggerty, 1962). Investigations into stress in utero
and the child’s immune system are, however, more recent.
Support for a role of prenatal stress and anxiety and child
immune function is suggested by several studies examining
asthma (Lefevre et al., 2011; Khashan et al., 2012) and infectious
disease (Nielsen et al., 2011) outcomes in children.
Perhaps the most direct test of the hypothesis that prenatal
anxiety alters specific indicators of the developing immune sys-
tem of the child was recently reported (O’Connor et al., 2013b).
In that study, infants whose mothers were characterized as anx-
ious in pregnancy, according to self-report and clinical evaluation,
exhibited poorer adaptive immune response at 6 months of
age. Altered or poorer adaptive immunity was measured from
humoral immunity, indexed by reduced hepatitis B antibody
titers following immunization (in vivo), and cell-mediated immu-
nity, indexed by increased IL-4 and decreased IFN-γ responder
cell frequencies to antigen (in vitro). The latter finding implies
that there is a reduced type 1 and increased type 2 response in the
infant; that is, consistent with other studies reviewed here, mater-
nal prenatal anxiety exaggerates the normal type 2 skewing and
less robust type 1 cytokine response to specific antigens (Ota et al.,
2004; PrabhuDas et al., 2011). These predictions were indepen-
dent of multiple confounds, including obstetric and psychosocial
factors. Additionally, Entringer et al. (2008) used a retrospec-
tive design to examine prenatal stress and immune function in
adult women. There was greater cytokine production of IL-4, IL-
10, and IL-6 in peripheral blood mononuclear cells (PBMCs) in
response to Phytohaemagglutinin (PHA) in adult women who
reported that their mother experienced a stress in pregnancy
compared to a non-prenatal stress group; there was no group
difference in lymphocyte subpopulations that were assessed.
A separate series of studies links immune markers in cord
blood with a broad index of stress. For example, perinatal stress
indexed by mode of delivery was associated with lymphocyte sub-
set distributions (Duijts et al., 2008). Also, Wright et al. (2010)
reported that a composite index of prenatal stress was associated
with increased IL-8 and TNF-α, increased IL-13 and decreased
IFN-γ in cord blood mononuclear cells; these cytokine responses
were observed in response to a range of stimuli, and the effects
depended on which stimuli was used. Furthermore, cord blood
immunoglobulin E (IgE) was linked with socio-economic disad-
vantage (Scirica et al., 2007), and IgE levels in the infant at birth
were predicted by chronic stress as reported bymothers (Sternthal
et al., 2009).
Collectively, the human data provide a strong suggestion that
maternal prenatal stress and anxiety may alter aspects of the
innate and adaptive immune systems in the child. In general
terms, that parallels what has been reported in numerous ani-
mal models. However, there remains some uncertainty about how
robust these associations in humans are, as there are few instances
of replication—likely a consequence of the novelty of this area
of research and the discrepant methods used across studies. At
present, the strongest finding is that maternal prenatal stress and
anxiety may exacerbate the type 2 response that is already present
in the newborn. Functional significance of the research on specific
immune markers is implied by survey studies associating prena-
tal anxiety or stress with specific illnesses, perhaps most notably
asthma.
MECHANISMS OF EFFECT
The most basic question for mechanistic research is how mater-
nal prenatal stress and anxiety is “communicated” to the fetus.
A first consideration here is that the maternal prenatal risk phe-
notype seems to be somewhat broad, including stress (objective
and subjective), anxiety (clinical elevations and continuous mea-
sures within the normal range), and possibly the broad construct
of negative affect, which would also include depression; other
constructs such as “pregnancy-specific” anxiety have been sug-
gested. It is to be expected—but not yet demonstrated—that the
prediction of child immune outcomes would not be particu-
lar to one maternal prenatal measure or construct. That means
that mechanistic research needs to consider what biological risk
may underlie these overlapping psychological constructs. In that
regard, each of these psychological measures is thought to acti-
vate stress pathways, especially the HPA axis and the sympathetic
nervous system; there is also a growing literature examining these
psychological measures in relation to specific immune function,
particularly inflammation. Importantly, each of these candidate
biological systems in the pregnant women satisfies a key crite-
rion: that the biological products of these systems pass through
the placenta, can alter placental function, or predict fetal response
(DiPietro et al., 2003; Glover et al., 2009; Monk et al., 2011;
O’Donnell et al., 2012).
The most popular candidate mechanism so far involves alter-
ation of the infant HPA axis in the child. This hypothesis is
based on two key observations. The first is that prenatal stress,
perhaps through alteration of the maternal HPA axis or the bar-
rier enzyme 11βHSD2 (O’Donnell et al., 2012), may alter the
function (e.g., set point, or reactivity) of the child’s HPA axis.
Evidence for this, which is soundly supported in experimental
animal work in several species, derives from several studies of
children (Van den Bergh et al., 2008; Davis et al., 2011; O’Connor
et al., 2013a; O’Donnell et al., 2013), each using a different
methodology. If the child’s HPA axis function is altered to a
higher set point or greater reactivity by maternal prenatal stress
and anxiety, as implied by at least some of these studies, then
that would predict a suppressed immune response in the infant
given the well-documented immune-suppressive effects of gluco-
corticoids on immune function parameters, and inflammation in
particular. Direct evidence for this connection is limited, but sev-
eral supportive and suggestive findings have been reported, such
as the weaker antibody titer response of pre-term infants who
were given dexamethasone, a synthetic glucocorticoid, to prevent
chronic lung disease (Robinson et al., 2004). In addition, thymus
development is sensitive to corticosteroids during fetal develop-
ment. Here again, however, it is important to provide specifics, as
immune-suppressive effects of glucocorticoids may not be global
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but rathermay bemore evident on type 1 cellular immunity, lead-
ing to a shift toward type 2-mediated immune response (Elenkov,
2004). Interestingly, that model is consistent with much of the
limited research onmaternal prenatal stress and anxiety and child
immune function reviewed above. And, more specifically, there
was some suggestive evidence that prenatal anxiety is associate
with reduced levels of IL-12, which is a main inducer of type 1
responses (O’Connor et al., 2013b).
An HPA axis-mediated effect is not the only possibility,
however. If maternal prenatal stress and anxiety is associated
with elevated inflammation, and the markers of inflammation
(e.g., pro-inflammatory cytokines) cross the placenta/alter pla-
cental function (which they do), then the fetus of prenatally
stressed and anxious women might then be exposed to elevated
immune responses early in development. Evidence supporting a
link between maternal anxiety, stress and depression and pro-
inflammatory cytokines in pregnancy has been reported in some
(Coussons-Read et al., 2007) but not other studies (Blackmore
et al., 2011), so the strength of this model is not yet clear. These
studies imply inconsistent evidence with specific immune mark-
ers; there is, on the other hand, a sizable literature showing that
maternal prenatal stress alters obstetric outcomes. Thus, mater-
nal stress has been linked with increased risk of miscarriage
(Neugebauer et al., 1996; Nepomnaschy et al., 2006), reproductive
tract infection (Culhane et al., 2001), and younger gestational age
at birth (Wadhwa et al., 1993). The presumption is that this may
be at least partly because of increased inflammation that endan-
gers the pregnancy, an association first demonstrated many years
ago (Harris, 1919). Other studies show that manipulating the
maternal immune system prenatally (through antibiotic use) may
alter the fetal/child immune system, leading in one instance to an
increased risk of asthma (Stensballe et al., 2012). Thus, a prenatal
programming mechanism might operate through immunologi-
cal changes in the mother that are then transferred more or less
directly to the developing fetus.
A further possibility is that morphological changes induced
by prenatal stress affect brain regions central to both HPA axis
and immune activity. For example, in research on several species,
animals exposed to prenatal stress show reductions in hippocam-
pal volume (Lemaire et al., 2000; Coulon et al., 2013). Human
studies on prenatal stress and brain morphology relevant to stress
response or immune functioning are now underway in several
labs; limited reported evidence so far does not suggest a link
between prenatal stress and reduced hippocampal volume in
children (Buss et al., 2012).
Challenges to each of these mechanisms abound. The human
research has not adequately addressed important confounds
ranging from nutrition (Monk et al., 2012) to genetics. In the
case of genetics, for example, many functional polymorphisms
of the glucocorticoid receptor (GR), mineralocorticoid receptor
(MR), corticotropin-releasing hormone (CRH), serotonin or
other genes may modulate the link between prenatal anxiety and
child outcomes, with one example with infant temperament so
far reported (Pluess et al., 2011), although there are large-scale
studies failing to replicate (Braithwaite et al., 2013), and so this
question remains unresolved. Additionally, the role of postnatal
rearing conditions, which has been studied extensively in several
animal species, e.g., non-human primates (Lubach et al., 1995),
has not yet been studied in relation to immune outcomes in
children. The possibility that caregiving may moderate the effects
of prenatal anxiety on other outcomes including behavioral and
cognitive development has been demonstrated (Bergman et al.,
2010).
Mechanistic studies are also hampered by an under-developed
model of psychoneuroimmunology. For example, we still lack
basic information on how the developing immune system in
the child responds in the short- and long-term, to brief or
chronic stress exposure. Much is known about the immune sys-
tem response to stress in the adult (perhaps especially the aged
adult), but it is far from clear if parallel responses are found in
children, or at what stage in development parallel links between
stress exposure and immune system response become robust.
That is because of the limited research on stress and immune sys-
tem development in pediatric samples, (e.g., see Caserta et al.,
2008, 2011; Low et al., 2013). And, clearly there will be some
difficulty in differentiating among “directions of effect” in inher-
ently bi-directional and mutually influencing systems, such as
the stress response and immune systems. So, for example, ele-
vated prenatal pro-inflammatory cytokines such as IL-1, IL-6,
and TNF-alpha may induce production of maternal prenatal
glucocorticoids through their action on the HPA axis, and this
may then lead to altered stress and immune function develop-
ment in the child. Recognizing the inter-dependent nature of the
stress and immune system development means that, for exam-
ple, targeting the stress response may have salutary effects on the
immune system and vice versa.
Good immune function is critically important for babies, who
must develop the cellular machinery to respond to immune chal-
lenges during fetal development but are nevertheless immuno-
logically immature at birth; furthermore, this pressure to mount
immune responses is intensified by an intensive vaccination
schedule. Not surprisingly, then, there is substantial interest in
how well babies’ immune systems respond to early challenges,
and what factors mediate individual differences. Understanding
how immune function development may be influenced by mater-
nal prenatal stress or anxiety is therefore important in its own
right. Moreover, understanding immune system challenge and
development might help explain some of the other neurodevel-
opmental outcomes thought to be causally linked with maternal
prenatal stress or anxiety. For example, as previously discussed,
there are clear linkages in animal studies (i.e., mouse and rat)
between cytokines levels and brain development (Meyer et al.,
2006; Patterson, 2009; Bilbo and Schwarz, 2012), and this path-
way explains some of the associations described linking maternal
viral or bacterial infection in pregnancy with neuropsychiatric
disorders (Susser et al., 2000; Brown et al., 2004, 2000b).
IMPLICATIONS FOR PREVENTION OF
NEURODEVELOPMENTAL DISORDER FOCUSING ON
NUTRITION
We emphasized in previous sections that optimal development of
the fetal immune system depends on adequate maternal nutri-
tional intake and that certain micronutrients play a particu-
larly important role. We also noted that the development of
www.frontiersin.org July 2013 | Volume 7 | Article 120 | 9
Marques et al. Nutrition, stress, immunology, neurodevelopmental disorders
the immune system may modulate the risk for later diseases,
including neurodevelopmental disorders. Taken together, these
observations raise the question of whether nutritional interven-
tions, and in particular, micronutrient supplements (to mother
or baby), could reduce the risk of neurodevelopmental disorders
by enhancing early development of the immune system.
Thus far, this question has rarely been addressed directly.
We have learned that certain micronutrient supplements both
reduce the risk of neurodevelopmental disorders and enhance
fetal immune development. But we do not know the relationship
between these two effects, or whether the impact of supplements
on immune development also contributes to the preventive effect.
A useful focus for future research would be to elucidate that
relationship, which could lead to a better understanding of the
mechanisms of prevention and in turn, perhaps improvements
in these interventions. From a global perspective, this is quite a
fundamental question for public health, because severe micronu-
trient deficiencies are widespread in developing countries, and
are associated with low birth weight, delayed neurodevelopment,
stillbirths, and perinatal and neonatal mortality (Ahmed et al.,
2012). The immunological development of the fetus or infant may
well play a role in vulnerability to these adverse outcomes (Trehan
et al., 2013).
There are several examples of broad nutritional interven-
tions (e.g., encouragement of breastfeeding), as well as many
examples of specific micronutrient supplements that fall within
this framework (that is, they enhance both immune develop-
ment and neurodevelopment but the relation between these
two effects remains unknown. For illustration, we have selected
three micronutrients—folate, iodine, and vitamin D—and dis-
cuss their proven and potential preventive effects on neurodevel-
opmental disorders.
FOLATE
In an earlier section we described how folate and other
B-vitamins can be pivotal for fetal immune development. With
respect to neurodevelopmental disorders, periconceptional folic
acid supplements have been proven to have a major preventive
effect. Worldwide, birth defects affect about 6% of live births
(Wallingford et al., 2013). Neural tube defects (NTDs) are one of
the most common congenital birth defects and one of the few for
which we have knowledge about preventive strategies. Folic acid
is a B-vitamin that is important for cell proliferation, (Zeisel,
2009) central nervous system cell repair, (Iskandar et al., 2010)
and appropriate epigenetic expression of the genome (Jaenisch
and Bird, 2003; Steegers-Theunissen et al., 2009), as well as for
immune development (Kjer-Nielsen et al., 2012). Randomized
controlled trials have demonstrated that periconceptional folic
acid supplements reduce the risk of NTDs (Prevention of
neural tube defects: results of the Medical Research Council
Vitamin Study, MRC Vitamin Study Research Group, 1991;
Czeizel and Dudas, 1992; Berry et al., 1999). All women of
childbearing age are recommended to take a folic acid supple-
ment of 400–800μg/d, preferably a month before conceiving.
In addition to public health campaigns to increase awareness
of taking prenatal folic acid supplements, the US Food and
Drug Administration mandated adding folic acid to all enriched
cereal grain products in 1998. This fortification policy has been
associated with a prevalence decline of 34% for spina bifida and
20% for anencephaly (Honein et al., 2001; Williams et al., 2002;
Canfield et al., 2005). Somewhat greater declines are reported
for Canada (De Wals et al., 2007) and Chile (Lopez-Camelo
et al., 2005). Early detection through prenatal screening is also
a likely contributor to lower prevalence; prenatal ultrasound at
gestational week 18–20 detects structural anomalies in about
60% of cases (Gagnon et al., 2009).
Recently, evidence is growing that periconceptional folic acid
supplements may have preventive effects on other neurodevel-
opmental disorders as well. These recent studies can be traced
in part to an intriguing finding from the Dutch Famine stud-
ies. The Dutch Hunger Winter was a period of severe starvation
in West Holland toward the end of the Second World War.
Gestational timing of starvation could be estimated because
severe famine was relatively brief and food supply was abruptly
restored when liberation arrived in May 1945. It was shown
that the offspring of women with periconceptional exposure
to severe famine—approximately one month before to two
months after conception—had an increased risk not only of
NTDs, but also of schizoid personality disorder at age 18 and
schizophrenia in adulthood (Susser et al., 1996, 1998; Brown
and Susser, 2008; Susser and St Clair, 2013). This coincident
increase in NTDs and other neurodevelopmental disorders nat-
urally led to the question of whether folic acid supplements
could have broader preventive effects. Several studies now sup-
port this view, although results are not definitive enough as
a basis for intervention. These include results from a large
Norwegian prospective pregnancy cohort, where use of pre-
natal folic acid supplements around the time of conception
has been associated with a lower risk of severe language delay
(Roth et al., 2011) and autistic disorder (Surén et al., 2012),
and a reduced risk of autism spectrum disorders was also
observed in a case-control study in California (Schmidt et al.,
2012).
IODINE
Iodine deficiency is the leading preventable cause of mental retar-
dation worldwide, and women of childbearing age and infants are
at particular risk (Trumpff et al., 2013). Iodine is a micronutri-
ent necessary for the production of thyroid hormones. Thyroid
hormones play an essential role in the central nervous system
during fetal and early postnatal life. Since iodine was not dis-
cussed in the earlier section on fetal immune development, we
note that increasing evidence suggests that the immune response
is modulated by thyroid hormones (De Vito et al., 2011).
About two billion people ingest too little iodine, and even
moderate deficiency is known to lower intelligence. Prevention
of iodine deficiency is easily managed by spraying regular table
salt with a potassium iodate solution at very low costs. Iodized
salts have been a true public health success story, with a rise in the
world’s household consumed iodized salt increasing from 25% in
1990 to 66% in 2006. Even so, it is presently a concern that iodine
deficiency still exists in some regions of the world and has reap-
peared in some European countries (Vanderpump et al., 2011;
Brantsaeter et al., 2013). The World Health Organization recently
raised their recommended dietary iodine intake in pregnancy
from 200 to 250μg/d (Zimmermann, 2009).
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VITAMIN D
We have described earlier how vitamin D is pivotal in early
immune development and it is also known to be crucial for early
skeletal development. It has been proposed, though not proven,
that low levels of vitamin D during pregnancy and infancy could
increase the risk of neurodevelopmental disorders, and that sup-
plementation could play a role in prevention. An intriguing body
of work comprising both rodents and human studies currently
supports this view, though no definitive conclusions have been
reached yet (Eyles et al., 2013; Pludowski et al., 2013; Yang et al.,
2013). Notably, in a recent population-based case control study
of 424 individuals with schizophrenia and 424 matched controls,
dried blood spots taken at birth were tested for vitamin D lev-
els (McGrath et al., 2010). When vitamin D levels were divided
into quintiles, the investigators observed an increased risk of
schizophrenia in individuals with vitamin D levels in the three
lowest quintiles compared to the fourth quintile. Surprisingly,
they also observed an increased risk for schizophrenia in individ-
uals with vitamin D levels in the highest quintile.
Notably, breastfed infants are at especially high risk of
vitamin D deficiency due to poor penetrance of vitamin D
metabolites in milk (Kovacs, 2013; Thiele et al., 2013). The
average level of vitamin D in breast milk is typically 25 IU
per liter or less. Fish oil (that commonly contains vitamin D)
and other Omega 3 fatty acid supplements taken in infancy
have been associated with improved cognitive development,
though this evidence is also far from definitive (Auestad et al.,
2003; Karr et al., 2011; Meldrum et al., 2012; Luchtman and
Song, 2013). The American Academy of Pediatrics recom-
mends that all breastfed infants receive a daily vitamin D sup-
plement of 400 IU, beginning in the first few days of life
(Wagner et al., 2008).
CONCLUSION
Early immune system programming can give rise to changes in the
fetal immune system that can persist over the life course. Evidence
based on animal, epidemiological and genetic studies suggests
that immune dysregulation in the developing brain may play a
role in neurodevelopmental disorders, such as autism spectrum
disorders and schizophrenia.
The interface between the maternal and fetal compartments
plays a central role in how the maternal immune system influ-
ences fetal and placental development. The maternal immune
system develops an active immune tolerance against fetal-placenta
antigens that arises from cell-cell interactions taking place
between maternal immune cells resident in the decidua and
trophoblast antigens. A range of protective immunoregulatory
mechanisms is also critical for the maintenance of a normal preg-
nancy, development of the fetal immune system, and maternal
immunocompetence. The development of the fetal immune sys-
tem is characterized by the presence of several distinct features
that promote fetal active tolerance against both in utero mater-
nal antigens and exogenous antigens, such as infectious agents,
vaccines and food antigens. This response pattern has impor-
tant implications for understanding the impact of prenatal and
early life exposure to infections, vaccines, and maternal immune
activation.
While well-controlled maternal immune responses play a pos-
itive physiological role in fetal immune and nervous system
development, an inappropriate maternal immune activation may
contribute to an increased risk in the offspring of neurodevel-
opmental disorders, autoimmune diseases and allergies later in
life. Disruption of the fetal immune system can affect the CNS
either by local or peripheral processes. Although the pathways by
which immune dysfunction can contribute to neurodevelopmen-
tal disorders are still not completely understood, the presence of
maternal antibodies, immune activation (maternal and fetal) and
imbalance of cytokine expression (pro- vs. anti-inflammatory) in
the fetal brain can exert a negative impact on brain development if
the time of exposure overlaps withmajor processes in neurodevel-
opment, such as cell migration, axonal elongation and dendritic
tree maturation. Animal studies on maternal immune activa-
tion have demonstrated that early life exposure to infections and
other factors that lead to immune activation may impose cogni-
tive, behavior and brain morphological abnormalities analogous
to findings described in patients with autism, schizophrenia and
other psychosis related disorders. These results are supported by
epidemiological studies linking maternal prenatal exposure to a
wide variety of infections (e.g., influenza, rubella, toxoplasma
gondii, etc.) with an increased risk for schizophrenia.
The fetal immune system is particularly vulnerable to environ-
mental insults (e.g., malnutrition, toxins, infections, and stress),
mainly during periods when tissue is seeded by precursors of
immune cells, which varies depending on the cell type (sensi-
tive window of immune vulnerability). However, deviations in
the maternal or fetal immune systems associated with prenatal
exposures should be interpreted with caution, as these may be the
result of healthy and normal adaptation responses to pregnancy.
Adequate maternal/fetal nutrition is also necessary for the
development of fetal and neonatal immune responses and
immune cell proliferation, placentation, and the development of
oral tolerance. Maternal malnutrition can reduce the supply of
nutrients and immune factors to the fetus (via the placenta) and
to the infant (via the mammary gland). In particular, mater-
nal micronutrient deficiencies in zinc, fat-soluble vitamins (e.g.,
vitamins A, D, E) and nutritional factors related to single car-
bon metabolism (e.g., choline, vitamins B2, B6, B12 and folate)
have been shown to play a role in cell-mediated and humoral
immune responses. They also have been associated with increased
offspring risk for respiratory infections (vitamin D), intestinal
inflammation and diarrhea (folate and vitamin A), allergy and
asthma (vitamin E and folate) and neurodevelopmental disorders
(folate). In addition, food-derived antigens have also been shown
to play a role in the development of the fetal immune system
(prenatal formation of antigen specific IgE), infant immune sys-
tem and brain development (oral tolerance and brain-gut-enteric
microbiota axis). Prenatal stress and anxiety may also alter aspects
of the offspring’s innate and adaptive immune systems. However,
uncertainty remains about how robust these associations are in
humans; the strongest finding is that maternal prenatal stress and
anxiety may exacerbate type 2 immune responses already present
in the newborn. It has been hypothesized that the impact of
maternal prenatal stress and anxiety on the fetal immune system
might operate through alteration of the maternal HPA axis,
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ultimately altering the function (e.g., set point, reactivity) of the
child’s HPA axis, with a higher set point or greater reactivity of
the infant HPA axis predicting a suppressed immune response.
Another hypothesis is that immunological changes in the mother
associated with maternal prenatal stress and anxiety (e.g., pro-
inflammatory cytokines) could cross the placenta and/or alter
placental function, consequently exposing the fetus to an elevated
immune response early in development.
Interestingly, several examples of nutritional interventions
(e.g., encouragement of breastfeeding and specific micronu-
trient supplements) have been shown to enhance both neu-
rodevelopment and immune development. However, it is still
not clear whether nutritional interventions, and, in partic-
ular micronutrient supplements (to mother or baby), could
reduce the risk of neurodevelopmental disorders by enhancing
early development of the immune system. We reported three
examples of micronutrients—folate, iodine, and vitamin D—
and discussed their proven and potential preventive effects on
neurodevelopmental disorders. Future studies are needed to
elucidate this relationship, which could contribute to a better
understanding of preventive mechanisms and, in turn, perhaps
improvements in these interventions.
Based on these findings, we suggest that integrating studies
of neurodevelopmental disorders and prenatal exposures (e.g.,
nutrition and stress) with simultaneous and precise neural and
immune system measures can potentially shed light on immuno-
logical mechanisms that underlie individual vulnerability or
resilience to neurodevelopmental disorders. This research could
ultimately contribute to the development of primary preventions
and early interventions for mental disorders.
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